Covered recipient · General Payments record
WILLIAM J OGLESBY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$604.88
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $439.07 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $124.47 | 1 |
| ABBVIE INC. | $89.21 | 4 |
| Acerta Pharma LLC | $76.89 | 3 |
| Astellas Pharma US Inc | $47.91 | 2 |
| Lilly USA, LLC | $37.54 | 2 |
| Exact Sciences Corporation | $33.77 | 2 |
| DEXCOM, INC. | $15.62 | 1 |
| Organon LLC | $13.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $124.47 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124847326 | CMS |
| ABBVIE INC. | $25.61 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105147546 | CMS |
| ABBVIE INC. | $19.51 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105147548 | CMS |
| ABBVIE INC. | $21.14 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105147550 | CMS |
| ABBVIE INC. | $22.95 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105147552 | CMS |
| Astellas Pharma US Inc | $23.27 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139304582 | CMS |
| Astellas Pharma US Inc | $24.64 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371203 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.41 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105696924 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.96 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105607589 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.52 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104607800 | CMS |
| Dexcom, Inc. | $15.62 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153344335 | CMS |
| Exact Sciences Corporation | $16.79 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114814871 | CMS |
| Exact Sciences Corporation | $16.98 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114814876 | CMS |
| Lilly USA, LLC | $15.63 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135470313 | CMS |
| Lilly USA, LLC | $21.91 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135504510 | CMS |
| Organon Llc | $13.66 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136197848 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.